Mutation of cancer cells. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy16

Cell Line, Tumor Tumor Cells, Cultured Cell Line HCT116 Cells MCF-7 Cells HT29 Cells Neoplastic Stem Cells HeLa Cells Breast Cell Nucleus Epithelial Cells HEK293 Cells Fibroblasts Cells, Cultured Mitochondria Prostate

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Escherichia coli Adenoviridae

Diseases33

Breast Neoplasms Colonic Neoplasms Ovarian Neoplasms Neoplasm Invasiveness Lung Neoplasms Neoplasms Pancreatic Neoplasms Neoplasm Metastasis Stomach Neoplasms Colorectal Neoplasms Genetic Predisposition to Disease Adenocarcinoma Prostatic Neoplasms Carcinoma Cell Transformation, Neoplastic Carcinoma, Non-Small-Cell Lung Disease Progression Urinary Bladder Neoplasms Carcinoma, Squamous Cell Uterine Cervical Neoplasms Neoplasms, Hormone-Dependent Endometrial Neoplasms Liver Neoplasms Neovascularization, Pathologic Bone Neoplasms Carcinoma, Small Cell Esophageal Neoplasms Disease Models, Animal Neoplasm Recurrence, Local Mammary Neoplasms, Experimental Neoplasms, Glandular and Epithelial Rectal Neoplasms Mouth Neoplasms

Chemicals and Drugs73

Antineoplastic Agents RNA, Messenger Neoplasm Proteins RNA, Small Interfering Tumor Suppressor Protein p53 DNA, Neoplasm DNA-Binding Proteins Transcription Factors DNA Primers Antineoplastic Agents, Phytogenic Tumor Markers, Biological Proto-Oncogene Proteins Receptors, Estrogen Nuclear Proteins Receptor, erbB-2 Membrane Proteins Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Proto-Oncogene Proteins c-akt Protein-Serine-Threonine Kinases Cancer Vaccines Codon, Nonsense Tamoxifen Cisplatin Receptors, Androgen Carrier Proteins RNA, Neoplasm DNA MicroRNAs Protein Kinase Inhibitors Enzyme Inhibitors Proto-Oncogene Proteins c-bcl-2 Anticarcinogenic Agents Paclitaxel Cell Cycle Proteins Androgens beta Catenin Recombinant Proteins Estrogen Receptor alpha Antibodies, Monoclonal ras Proteins Antigens, Neoplasm Codon Apoptosis Regulatory Proteins Repressor Proteins Phosphatidylinositol 3-Kinases Caspases BRCA2 Protein Caspase 3 Cadherins Proteins Prostate-Specific Antigen Proto-Oncogene Proteins B-raf Receptors, Progesterone Fluorouracil Mutant Proteins Quinazolines Antimetabolites, Antineoplastic BRCA1 Protein Adaptor Proteins, Signal Transducing Antibiotics, Antineoplastic Antineoplastic Agents, Hormonal Inhibitor of Apoptosis Proteins PTEN Phosphohydrolase Estrogens Cyclin-Dependent Kinase Inhibitor p21 Recombinant Fusion Proteins DNA, Complementary Trans-Activators Cyclin D1 Intracellular Signaling Peptides and Proteins Estradiol Estrogen Antagonists

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Reverse Transcriptase Polymerase Chain Reaction Pedigree Early Detection of Cancer Blotting, Western Transfection Xenograft Model Antitumor Assays Drug Screening Assays, Antitumor Polymerase Chain Reaction DNA Mutational Analysis Neoplasm Transplantation Amino Acid Substitution Gene Expression Profiling Transplantation, Heterologous Sequence Analysis, DNA Gene Knockdown Techniques Immunohistochemistry Mutagenesis, Site-Directed Prognosis Genetic Testing Models, Biological Oligonucleotide Array Sequence Analysis Flow Cytometry Survival Analysis Antineoplastic Combined Chemotherapy Protocols Inhibitory Concentration 50 Survival Rate Tumor Burden Chromosome Mapping Models, Molecular Neoplasm Staging Molecular Targeted Therapy Immunoblotting Retrospective Studies Cloning, Molecular Risk Real-Time Polymerase Chain Reaction Follow-Up Studies Models, Genetic Sensitivity and Specificity Tumor Stem Cell Assay Disease Models, Animal Prospective Studies Immunoprecipitation Genetic Therapy Disease-Free Survival Combined Modality Therapy Registries Risk Assessment Mammary Neoplasms, Experimental Immunoenzyme Techniques Sequence Alignment

Phenomena and Processes78

Point Mutation Mutation, Missense Mutation Gene Expression Regulation, Neoplastic Frameshift Mutation Germ-Line Mutation Apoptosis Cell Proliferation Base Sequence Drug Resistance, Neoplasm Signal Transduction Cell Survival Transfection Cell Division Exons Cell Cycle Cell Movement Down-Regulation Promoter Regions, Genetic Mutation Rate Heterozygote Alleles Genotype RNA Interference Amino Acid Sequence Amino Acid Substitution Phenotype Genetic Predisposition to Disease Phosphorylation Cell Growth Processes Polymorphism, Single-Stranded Conformational Transcription, Genetic Genes, p53 Gene Silencing Protein Binding Dose-Response Relationship, Drug Up-Regulation Gene Expression Homozygote Drug Synergism Protein Structure, Tertiary Mutagenesis Genes, BRCA1 Binding Sites Codon, Nonsense Polymorphism, Genetic Genes, Tumor Suppressor Sequence Deletion Enzyme Activation Genes, Dominant Inhibitory Concentration 50 Gene Deletion Genes, Recessive Time Factors Codon Cell Adhesion Epithelial-Mesenchymal Transition DNA Repair Cell Death Risk Plasmids Suppression, Genetic Transcriptional Activation Sequence Homology, Amino Acid Genes, BRCA2 Sensitivity and Specificity Microsatellite Repeats Radiation Tolerance DNA Methylation Genes, Neoplasm Structure-Activity Relationship Genetic Vectors Kinetics Gene Amplification Loss of Heterozygosity Gene Expression Regulation Genetic Variation Gene Frequency

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Information Science5

Base Sequence Molecular Sequence Data Amino Acid Sequence Survival Rate Registries

Health Care14

Genetic Testing Survival Analysis Survival Rate Retrospective Studies Risk Follow-Up Studies National Cancer Institute (U.S.)Sensitivity and Specificity Family Health Prospective Studies Disease-Free Survival Registries Risk Assessment Age Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care

Point Mutation Mutation, Missense Mutation Breast Neoplasms Gene Expression Regulation, Neoplastic Cell Line, Tumor Frameshift Mutation Tumor Cells, Cultured Germ-Line Mutation Apoptosis Colonic Neoplasms Cell Proliferation Antineoplastic Agents Mice, Nude Ovarian Neoplasms Neoplasm Invasiveness Lung Neoplasms Neoplasms Base Sequence Drug Resistance, Neoplasm RNA, Messenger Neoplasm Proteins Pancreatic Neoplasms Reverse Transcriptase Polymerase Chain Reaction Pedigree RNA, Small Interfering Early Detection of Cancer Blotting, Western Neoplasm Metastasis Signal Transduction Molecular Sequence Data Cell Survival Stomach Neoplasms Transfection Xenograft Model Antitumor Assays Cell Division Exons Drug Screening Assays, Antitumor Cell Cycle Cell Movement Polymerase Chain Reaction Down-Regulation Promoter Regions, Genetic Tumor Suppressor Protein p53 Mutation Rate DNA Mutational Analysis Heterozygote DNA, Neoplasm Alleles Genotype DNA-Binding Proteins Colorectal Neoplasms Transcription Factors Neoplasm Transplantation RNA Interference Amino Acid Sequence Cell Line Amino Acid Substitution Gene Expression Profiling HCT116 Cells DNA Primers Phenotype Genetic Predisposition to Disease Adenocarcinoma Phosphorylation Prostatic Neoplasms MCF-7 Cells Transplantation, Heterologous Carcinoma Cell Transformation, Neoplastic Cell Growth Processes Polymorphism, Single-Stranded Conformational HT29 Cells Antineoplastic Agents, Phytogenic Transcription, Genetic Genes, p53 Gene Silencing Protein Binding Carcinoma, Non-Small-Cell Lung Dose-Response Relationship, Drug Tumor Markers, Biological Proto-Oncogene Proteins Up-Regulation Receptors, Estrogen Disease Progression Nuclear Proteins Urinary Bladder Neoplasms Receptor, erbB-2 Membrane Proteins Receptor, Epidermal Growth Factor Sequence Analysis, DNA Gene Expression Gene Knockdown Techniques Immunohistochemistry Mutagenesis, Site-Directed Tumor Suppressor Proteins Prognosis Homozygote Genetic Testing Proto-Oncogene Proteins c-akt

No FAQ available that match "mutation of cancer cells"